Pfizer Inc. 13D and 13G filings for Cellectis S.A.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 2:24 pm Purchase | 2023-12-31 | 13G | Cellectis S.A. CLLS | PFIZER INC PFE | 2,786,924 3.890% | 2,786,924 (New Position) | Filing |